professor profile picture

Matthias Herth

Professor for Radiopharmaceutical Chemistry

University of Copenhagen

Country flag

Denmark

This profile is automatically generated from trusted academic sources.

Google Scholar

.

ORCID

.

LinkedIn

Social connections

How do Indian students reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI

Contact this professor

Research Interests

Pharmaceutical Chemistry

10%

Organic Chemistry

10%

Chemistry

10%

Cancer Therapy

10%

Radiopharmaceutical Chemistry

10%

Medical Science

10%

Theranostic

10%

Ask ApplyKite AI

Start chatting
How can you help me contact this professor?
What are this professor's research interests?
How should I write an email to this professor?

Positions1

Publisher
source

Matthias Herth

University Name
.

University of Copenhagen

3 Postdoctoral Positions in Radiopharmaceutical Chemistry, Medicinal Chemistry, and Translational Radiochemistry at University of Copenhagen

The Herth Group at the University of Copenhagen is recruiting three postdoctoral researchers for 2-year positions in the fields of radiopharmaceutical chemistry, medicinal/organic chemistry, and translational radiochemistry & technology. The research focuses on the development of next-generation astatinated radiopharmaceuticals for cancer therapy, including neuroendocrine tumors and ovarian cancer, with projects spanning from discovery to clinical translation. The positions are embedded in a highly interdisciplinary and translational environment, involving close collaboration with GMP production, clinical application, and industrial partners. Research areas include radiopharmaceutical chemistry (development of new radiolabeling strategies for astatine-211–labeled drug candidates), medicinal/organic chemistry (structure–activity relationship studies, optimization of lead compounds, and development of molecular targeting modules for CAR T cell therapy), and translational radiochemistry (automation, upscaling, and transfer to synthesis modules). The group employs advanced radiolabelling technologies, machine-learning-supported optimization, and a bench-to-bedside approach, targeting both small molecules and larger biomolecules such as monoclonal antibodies and nanobodies. Applicants should have a PhD in a relevant field (radiochemistry, radiopharmaceutical chemistry, engineering, medicinal chemistry, or organic chemistry), strong hands-on experience, and a clear interest in translational drug development. The positions offer creative and stimulating working conditions in a dynamic, international research environment, with access to modern laboratories and advanced radiochemistry infrastructure. The monthly salary starts at 39,000 DKK (approx. 5,200 EUR), with a 17.1% pension contribution and potential tax reductions for eligible foreign applicants. The application deadline is March 1, 2026, and the expected start date is June 1, 2026, or shortly thereafter. For more information, visit the official job postings or contact Professor Matthias Herth at [email protected]. Application materials must include a motivated letter, CV, degree certificates, and publication list, submitted online via the provided links.

1 week ago